ZIOPHARM ONCOLOGY INC (64) | Separation Agreements (3)
- Separation Agreement, dated March 28, 2022, by and between the Registrant and Dr. Raffaele Baffa (Filed With SEC on March 30, 2022)
- Separation Agreement by and between the Company and Dr. Laurence Cooper, dated April 5, 2021 (Filed With SEC on April 9, 2021)
- Separation Agreement and Release by and between the Company and Dr. David Mauney, effective May 26, 2020 (Filed With SEC on May 29, 2020)
